AG
IMMU

Aperio Group’s Immunomedics Inc IMMU Stock Holding History

Aperio Group’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-49,236
Closed -$4.19M – 2467
2020
Q3 		$4.19M Buy
49,236
+17,147
+53% +$867K 0.01% 801
2020
Q2 		$1.14M Buy
32,089
+13,181
+70% +$385K ﹤0.01% 1355
2020
Q1 		$255K Sell
18,908
-5,324
-22% -$89.6K ﹤0.01% 1996
2019
Q4 		$513K Buy
24,232
+3,947
+19% +$69.6K ﹤0.01% 1785
2019
Q3 		$269K Buy
20,285
+8,855
+77% +$130K ﹤0.01% 2063
2019
Q2 		$159K Sell
11,430
-3,102
-21% -$46.7K ﹤0.01% 2250
2019
Q1 		$279K Buy
14,532
+1,597
+12% +$25.7K ﹤0.01% 2033
2018
Q4 		$185K Buy
+12,935
New +$257K ﹤0.01% 2153

Aperio Group's IMMU Position: Q4 2020 in Review

Aperio Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 49,236 shares — an estimated $4.19M sold.

Aperio Group first reported a position in IMMU in Q4 2018 and held it in 8 quarters. The position peaked at $4.19M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Aperio Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Aperio Group sold 49,236 Immunomedics Inc shares in Q4 2020, an estimated $4.19M.
  • Aperio Group first reported a position in Immunomedics Inc in Q4 2018 and held it in 8 quarters.
  • Aperio Group's Immunomedics Inc position peaked at $4.19M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.